Allopregnanolone concentrations and premenstrual syndrome

European Journal of Endocrinology

Volumn 142, Issue 3, 2000, Pages 269-273

  Monteleone, Patrizia ^a   Luisi, Stefano ^a   Tonetti, Arianna ^a   Bernardi, Francesca ^a   Genazzani, Alessandro D ^c   Luisi, Michele ^b   Petraglia, Felice ^d   Genazzani, Andrea R ^a  

^a UNIVERSITY OF PISA   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d UNIVERSITY OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; ESTRADIOL; GONADORELIN; PROGESTERONE;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MENSTRUAL CYCLE; MENSTRUATION DISORDER; NEUROENDOCRINOLOGY; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; RADIOIMMUNOASSAY; STEROID BLOOD LEVEL;

EID: 0034103825     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1420269     Document Type: Article

References (14)

1. Rubinow DR, Hoban MC, Grover GN, Galloway S, Roy-Byrne P, Andersen R et al. Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. American Journal of Obstetrics and Gynecology 1988 158 5-11.
2. Backstrom T, Sanders D, Leask R, Davidson D, Warner P & Bancroft J, Mood, sexuality, hormones, and the menstrual cycle: hormone levels and their relationship to the Premenstrual syndrome. Psychasomatic Medicine 1983 45 503-507.
3. Seippel L & Backstrom T, Luteal-phase estradiol relates to symptom severity in patients with premenstrual syndrome. Journal of Clinical Endocrinology and Metabolism 1998 83 1992-1998.
4. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF & Rubinow DR. Differential behavioural effects of gonadal steroids in women with and in those without premenstrual syndrome. New England Journal of Medicine 1998 338 209-216.
5. Majewska MD, Harrison R & Schwartz R. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 1986 232 1004.
6. Majewska MD. Neurosteroids: endogenous bimodal modulators of the GABA-A receptor. Mechanism of action and physiological significance. Progress in Neurobiology 1992 38 379-395.
7. A receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 1998 392 926-930.
8. Wang M, Seippel L, Purdy RH & Backstrom T. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone sulfate, 5α-pregnan-3, 20-dione and 3α-hydroxy-5α-pregnan-20-one. Journal of Clinical Endocrinology and Metabolism 1996 81 1076-1082.
9. Schmidt PJ, Purdy RH, Moore PH, Paul SM & Rubinow DR. Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. Journal of Clinical Endocrinology and Metabolism 1994 79 1256-1260.
10. Bicikova M, Dibbelt L, Hill M, Hampl R & Starka L. Allopregnanolone in women with premenstrual syndrome. Hormone and Metabolic Research 1998 30 227-230.
11. Rapkin AJ, Morgan M. Goldman L, Brann DW, Simone D & Mahesh VB. Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstetrics and Gynecology 1997 90 709-714.
12. Genazzani AR, Petraglia F, Bernardi F, Casarosa E. Salvestroni C, Tonetti A et al. Circulating levels of allopregnanolone in humans: gender, age and endocrine influences. Journal of Clinical Endoccrinology and Metabolism 1998 83 2099-2105.
13. Hinney B, Henze C, Kuhn W & Wuttke W. The corpus luteum deficiency: a multifactorial disease. Journal of Clinical Endocrinology Metabolism 1996 81 365-370.
14. Sundstrom I, Andersson A, Nyberg S, Ashbrook D, Purdy RH & Backstrom T. Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the mentrual cycle compared with control subjects. Neuroendocrinology 1998 7 126-138.